3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Immunology - Pregnancy -

Pregnancy outcome affected by immune system genes

Immunology • • PregnancyOct 26, 10

A team of researchers, led by Ashley Moffett, at the University of Cambridge, United Kingdom, has shed new light on genetic factors that increase susceptibility to and provide protection from common disorders of pregnancy, specifically recurrent miscarriage, preeclampsia, and fetal growth restriction.

A key step in the initiation of a successful pregnancy is the invasion of the lining of the uterus by fetal cells known as trophoblasts, which become the main cell type of the placenta. Recurrent miscarriage, preeclampsia, and fetal growth restriction are thought to result from inadequate trophoblast invasion of the uterus lining. Interactions between maternal cells known as uterine NK cells and fetal trophoblasts — specifically interactions between HLA-C molecules on the fetal trophoblasts and KIRs on the maternal uterine NK cells — are key to determining the extent of trophoblast invasion. Previous data from Moffett’s lab indicated that a particular combination of fetal HLA-C and maternal KIR was associated with increased risk of preeclampsia. In this study, the team has extended this correlation to recurrent miscarriage and fetal growth restriction. Furthermore, they have determined that the presence of other maternal KIRs that combine with the same HLA-C molecule provides protection against the same common disorders of pregnancy.

In an accompanying commentary, Peter Parham and Lisbeth Guethlein, at Stanford University, discuss the importance of these data and how they might explain distinct immune system gene expression patterns in different populations.

###

TITLE: Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2

AUTHOR CONTACT:
Ashley Moffett
University of Cambridge, Cambridge, United Kingdom.
Phone: 44.1223.333729; Fax: 44.1223.765065; E-mail: .(JavaScript must be enabled to view this email address).

View this article at: http://www.jci.org/articles/view/43998?key=cfb4e33703c44a22516f

ACCOMPANYING COMMENTARY
TITLE: Pregnancy immunogenetics: NK cell education in the womb?

AUTHOR CONTACT:
Peter Parham
Stanford University, Stanford, California, USA.
Phone: 650.723.7456; Fax: 650.723.8464; E-mail: .(JavaScript must be enabled to view this email address).

###

Contact: Karen Honey
.(JavaScript must be enabled to view this email address)
734-546-5242
Journal of Clinical Investigation



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Drug prevents passage of HBV during pregnancy
  Designing better medical implants
  Baclofen shows promise in patients with alcohol-induced liver disease
  BGI study confirms accuracy of its NIFTY in nearly 147,000 pregnancies
  Scientists discover potential new target for cancer immunotherapy
  Arkansas to appeal ruling on abortion restriction law
  Immune system ‘overdrive’ in pregnant women puts male child at risk for brain disorders
  Testosterone-regulated genes may affect vaccine-induced immunity
  Is it safe for pregnant women to eat peanuts?
  Fungus-fighting drug may make mild flu meaner
  Stanford scientists think mysterious virus could be a signal of a weak immune system
  Nearly half of U.S. children late receiving vaccines

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site